---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000117"
form_type: "8-K"
ticker: "CL"
cik: "0000021665"
company_name: "COLGATE PALMOLIVE CO"
filed_at: "2022-01-28T23:59:59+00:00"
generated_at: "2026-06-27T14:23:08.304240+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Colgate Q4/FY2021: organic sales +4.5% FY; GAAP EPS down 19% on impairment; launches $200-240M productivity plan

## Summary
- Full year net sales $17.42B (+6.0% YoY); organic sales growth +4.5%.
- GAAP diluted EPS $2.55 (-19% YoY) due to Filorga goodwill impairment; base business EPS $3.21 (+5%).
- Q4 net sales +2.0%, organic +3.0%; oral care and pet nutrition accelerated.
- Board approved 2022 Global Productivity Initiative; estimated pre-tax charges $200-240M (80% severance), substantially complete by Dec 2022.

## SEC filing metadata
- accession: 0001157523-22-000117
- form_type: 8-K
- ticker: CL
- cik: 0000021665
- company_name: COLGATE PALMOLIVE CO
- filed_at: 2022-01-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21665/000115752322000117/0001157523-22-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21665/000115752322000117/a52570001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000117
- JSON: https://secwatch.observer/filing/0001157523-22-000117.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.